Related Experiment Video
Updated: Jun 26, 2026

07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Blood-Ocular Barrier Dysfunction in Uveitis: A Bidirectional Model Linking Pathogenesis, Clinical Monitoring, and
Yijin Chen1, Mingming Yang1, Yaru Zou1
1Department of Ophthalmology and Visual Science, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8519, Japan.
Medical Sciences (Basel, Switzerland)
|June 25, 2026
Summary
Uveitis inflammation disrupts the blood-ocular barrier (BOB), leading to persistent disease. Assessing BOB dysfunction offers new ways to monitor uveitis and prevent relapses.
Area of Science:
- Ophthalmology
- Immunology
- Cell Biology
Background:
- Uveitis is a major cause of vision loss, characterized by intraocular inflammation.
- Current treatments targeting inflammation often fail to prevent chronic or recurrent disease.
- The blood-ocular barrier (BOB) regulates the intraocular environment and is implicated in uveitis.
Purpose of the Study:
- To review the bidirectional relationship between intraocular inflammation and BOB dysfunction in uveitis.
- To highlight the clinical significance of BOB dysfunction in disease monitoring and management.
- To discuss incorporating BOB assessment into uveitis evaluation and relapse-aware strategies.
Main Methods:
- Literature review summarizing recent studies on uveitis and BOB.
- Analysis of the interplay between inflammatory mediators and barrier integrity.
- Evaluation of clinical findings reflecting BOB status.
Main Results:
- Inflammation and BOB dysfunction are bidirectionally linked, forming a self-reinforcing cycle.
- BOB dysfunction facilitates immune cell infiltration and amplifies inflammation.
- Clinical signs like aqueous flare and edema indicate barrier status and aid monitoring.
Conclusions:
- BOB dysfunction is a key factor in uveitis persistence and recurrence.
- Assessing BOB integrity provides valuable insights beyond conventional inflammation markers.
- Incorporating BOB assessment can improve uveitis management, leading to better disease control and reduced relapse risk.
Related Concept Videos
Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

